Oscar Health, Inc. (NYSE:OSCR) Given Consensus Rating of “Moderate Buy” by Analysts

Shares of Oscar Health, Inc. (NYSE:OSCR) have been given a consensus rating of “Moderate Buy” by the nine ratings firms that are presently covering the company, MarketBeat.com reports. Three research analysts have rated the stock with a hold recommendation, five have given a buy recommendation and one has given a strong buy recommendation to the company. The average 12 month price objective among analysts that have updated their coverage on the stock in the last year is $19.75.

OSCR has been the subject of several research analyst reports. Wells Fargo & Company raised their price objective on Oscar Health from $24.00 to $27.00 and gave the stock an “overweight” rating in a research note on Wednesday, June 12th. Bank of America restated a “neutral” rating and set a $21.00 price objective (down from $25.00) on shares of Oscar Health in a research note on Thursday, May 30th. The Goldman Sachs Group increased their price objective on shares of Oscar Health from $16.00 to $21.00 and gave the stock a “neutral” rating in a research note on Thursday, May 9th. Baird R W raised shares of Oscar Health to a “strong-buy” rating in a report on Thursday, May 30th. Finally, Robert W. Baird initiated coverage on shares of Oscar Health in a report on Thursday, May 30th. They issued an “outperform” rating and a $28.00 price target on the stock.

Oscar Health Trading Down 10.4 %

Shares of Oscar Health stock opened at $15.82 on Wednesday. The firm’s 50 day simple moving average is $19.49 and its two-hundred day simple moving average is $15.42. The firm has a market capitalization of $3.75 billion, a price-to-earnings ratio of -39.55 and a beta of 1.68. Oscar Health has a 12-month low of $4.72 and a 12-month high of $23.44. The company has a current ratio of 1.10, a quick ratio of 1.10 and a debt-to-equity ratio of 0.29.

Oscar Health (NYSE:OSCR) last released its earnings results on Tuesday, May 7th. The company reported $0.62 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.28 by $0.34. Oscar Health had a negative return on equity of 5.77% and a negative net margin of 0.82%. The firm had revenue of $2.14 billion for the quarter, compared to the consensus estimate of $1.99 billion. During the same period in the prior year, the firm earned ($0.18) EPS. The firm’s revenue was up 45.8% on a year-over-year basis. Analysts predict that Oscar Health will post -0.05 EPS for the current year.

Insider Activity

In related news, CAO Victoria Baltrus sold 7,674 shares of the company’s stock in a transaction dated Monday, June 3rd. The stock was sold at an average price of $19.46, for a total value of $149,336.04. Following the completion of the transaction, the chief accounting officer now owns 127,754 shares of the company’s stock, valued at approximately $2,486,092.84. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other Oscar Health news, CAO Victoria Baltrus sold 7,674 shares of the stock in a transaction on Monday, June 3rd. The shares were sold at an average price of $19.46, for a total transaction of $149,336.04. Following the transaction, the chief accounting officer now directly owns 127,754 shares of the company’s stock, valued at $2,486,092.84. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, CFO Richard Scott Blackley sold 24,016 shares of the business’s stock in a transaction dated Monday, June 3rd. The stock was sold at an average price of $19.46, for a total transaction of $467,351.36. Following the sale, the chief financial officer now directly owns 643,546 shares of the company’s stock, valued at approximately $12,523,405.16. The disclosure for this sale can be found here. Insiders have sold 81,655 shares of company stock worth $1,589,006 in the last ninety days. Company insiders own 25.11% of the company’s stock.

Hedge Funds Weigh In On Oscar Health

Hedge funds have recently made changes to their positions in the company. Swiss National Bank grew its holdings in shares of Oscar Health by 9.9% in the third quarter. Swiss National Bank now owns 281,900 shares of the company’s stock valued at $1,570,000 after purchasing an additional 25,400 shares during the period. Charles Schwab Investment Management Inc. increased its holdings in shares of Oscar Health by 19.3% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,125,355 shares of the company’s stock worth $6,268,000 after buying an additional 182,206 shares during the last quarter. QRG Capital Management Inc. purchased a new stake in shares of Oscar Health during the 3rd quarter valued at approximately $117,000. Dark Forest Capital Management LP acquired a new position in Oscar Health in the third quarter valued at approximately $581,000. Finally, Federated Hermes Inc. grew its position in Oscar Health by 19,729.0% in the third quarter. Federated Hermes Inc. now owns 290,099 shares of the company’s stock worth $1,616,000 after acquiring an additional 288,636 shares during the period. Institutional investors and hedge funds own 75.70% of the company’s stock.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.